In this article (Cancer Epidemiol Biomarkers Prev 2009;18:1003–6), which was published in the March 2009 issue of Cancer Epidemiology, Biomarkers & Prevention (1), the units of plasma folate in Table 2 were incorrectly printed as μg/mL. The correct units are ng/mL. A corrected table is shown below. The authors regret the error.
Table 2.
. | Plasma folate tertiles . | |||
---|---|---|---|---|
. | T1 (low) . | T2 . | T3 . | . |
. | 2.04–7.54 ng/mL . | 7.55–11.09 ng/mL . | 11.10–304.00 ng/mL . | . |
. | OR (95% CI) . | OR (95% CI) . | OR (95% CI) . | Ptrend . |
Cases | 96 | 95 | 112 | |
Controls | 396 | 396 | 396 | |
OR (95% CI) | 1.0 (ref) | 1.0 (0.7–1.3) | 1.2(0.8–1.7) | 0.30 |
Diet | Pinteraction | |||
Methionine | ||||
Low | 1.0 (ref) | 0.9 (0.6–1.4) | 1.2 (0.8–1.9) | |
High | 1.0 (0.6–1.6) | 1.0 (0.6–1.6) | 1.1 (0.7–1.9) | 0.52 |
Vitamin B12 | ||||
Low | 1.0 (ref) | 0.9 (0.6–1.5) | 1.1 (0.7–1.7) | |
High | 0.9 (0.6–1.5) | 0.9 (0.6–1.5) | 1.2 (0.8–2.0) | 0.69 |
Vitamin B6 | ||||
Low | 1.0 (ref) | 0.6 (0.4–1.0) | 1.3 (0.8–2.0) | |
High | 0.8 (0.5–1.3) | 1.1 (0.7–1.8) | 1.0 (0.6–1.6) | 0.40 |
Niacin (B3) | ||||
Low | 1.0 (ref) | 0.7 (0.4–1.1) | 1.2 (0.7–1.8) | |
High | 0.6 (0.4–1.0) | 0.8 (0.5–1.3) | 0.8 (0.5–1.3) | 0.50 |
Riboflavin (B2) | ||||
Low | 1.0 (ref) | 0.8 (0.5–1.3) | 1.0 (0.7–1.6) | |
High | 0.9 (0.5–1.5) | 1.0 (0.6–1.6) | 1.2 (0.7–2.0) | 0.75 |
. | Plasma folate tertiles . | |||
---|---|---|---|---|
. | T1 (low) . | T2 . | T3 . | . |
. | 2.04–7.54 ng/mL . | 7.55–11.09 ng/mL . | 11.10–304.00 ng/mL . | . |
. | OR (95% CI) . | OR (95% CI) . | OR (95% CI) . | Ptrend . |
Cases | 96 | 95 | 112 | |
Controls | 396 | 396 | 396 | |
OR (95% CI) | 1.0 (ref) | 1.0 (0.7–1.3) | 1.2(0.8–1.7) | 0.30 |
Diet | Pinteraction | |||
Methionine | ||||
Low | 1.0 (ref) | 0.9 (0.6–1.4) | 1.2 (0.8–1.9) | |
High | 1.0 (0.6–1.6) | 1.0 (0.6–1.6) | 1.1 (0.7–1.9) | 0.52 |
Vitamin B12 | ||||
Low | 1.0 (ref) | 0.9 (0.6–1.5) | 1.1 (0.7–1.7) | |
High | 0.9 (0.6–1.5) | 0.9 (0.6–1.5) | 1.2 (0.8–2.0) | 0.69 |
Vitamin B6 | ||||
Low | 1.0 (ref) | 0.6 (0.4–1.0) | 1.3 (0.8–2.0) | |
High | 0.8 (0.5–1.3) | 1.1 (0.7–1.8) | 1.0 (0.6–1.6) | 0.40 |
Niacin (B3) | ||||
Low | 1.0 (ref) | 0.7 (0.4–1.1) | 1.2 (0.7–1.8) | |
High | 0.6 (0.4–1.0) | 0.8 (0.5–1.3) | 0.8 (0.5–1.3) | 0.50 |
Riboflavin (B2) | ||||
Low | 1.0 (ref) | 0.8 (0.5–1.3) | 1.0 (0.7–1.6) | |
High | 0.9 (0.5–1.5) | 1.0 (0.6–1.6) | 1.2 (0.7–2.0) | 0.75 |
NOTE: Adjusted for age, educational attainment, baseline household income, smoking status, drinking status, physical activity, hormone replacement therapy, menopausal status, family history of colorectal cancer, body mass index, NSAID use, use of a vitamin B supplement, history of colorectal polyps, diabetes history, and daily intakes of energy, vegetables, fruits, red meats, and calcium.
References
1.
Shrubsole
MJ
, Yang
G
, Gao
YT
, Chow
WH
, Shu
XO
, Cai
Q
, et al Dietary B vitamin and methionine intakes and plasma folate are not associated with colorectal cancer risk in Chinese women
. Cancer Epidemiol Biomarkers Prev
2009
;18
:1003
–6
.©2012 American Association for Cancer Research.
2012